Clinical trial shows superior preservation of donor lungs at 10 degrees

Image source: Adobe Stock/Robert Kneschke

News • Surgery

Clinical trial shows superior preservation of donor lungs at 10 degrees

Storing donor lungs for transplant at 10 degrees Celsius markedly increases the length of time the organ can live outside the body according to research led by a team of scientists at the Toronto Lung Transplant Program in the Ajmera Transplant Centre at the University Health Network (UHN).

The prospective multicenter, nonrandomized clinical trial study of 70 patients demonstrated that donor lungs remained healthy and viable for transplant up to four times longer compared to storage at the current standard of ice cooler preservation of around 4 degrees Celsius.

Results of the trial have recently been published in the NEJM Evidence.

The clinical impact of this study is huge. It's a paradigm shift for the practice of lung transplant

Dr. Marcelo Cypel

"The clinical impact of this study is huge. It's a paradigm shift for the practice of lung transplant," says lead author Dr. Marcelo Cypel, Surgical Director of the Ajmera Transplant Centre and a surgeon within the Sprott Department of Surgery at UHN.

"I have no doubt that this will become the gold standard practice of lung preservation for the foreseeable future."

Shortage of donor lungs

Lungs available for transplant are currently limited by the length of time a donor organ can be kept viable. Increasing storage time allows for viable donor lungs to come from greater distances, increasing the potential for greater numbers of lungs becoming available for transplant and overcoming many of the hurdles around transplant logistics.

"In transplant, we still see a critical shortage of organs and people dying on the waitlist because there are not enough lungs to be transplanted," says Dr. Cypel, who is also a Professor in the Division of Thoracic Surgery, Department of Surgery at U of T.

"It's a great accomplishment to see that our research is now having an impact, and that we can actually have more cases done at our center, with continued outstanding clinical results. Better organ preservation also means better outcomes for patients."

Clinical trial: Extending the lifespan of donor lungs

Photo
Kaplan–Meier 1-Year Recipient Survival Curve. CI denotes confidence interval.
Source: NEJM Evidence (2023). DOI: 10.1056/EVIDoa2300008

The trial took place over 18 months at UHN's Toronto General Hospital, the Medical University of Vienna, and Hospital Universitario Puerta de Hierro-Majadahonda in Madrid.

"The ability to extend the lifespan of the donor organ poses several advantages. Ultimately, these advantages will allow for more lungs to be utilized across farther geographies and the ability to improve recipient outcomes by converting lung transplantation into a planned rather than urgent procedure," says study first author Dr. Aadil Ali, Adjunct Scientist at the Toronto General Hospital Research Institute.

Some advantages of this new 10 degrees Celsius standard for lung storage include the potential to reduce or eliminate the 24/7 schedule and urgency of lung transplant procedures. By increasing the length of time donor lungs are viable, transplant surgeries could become planned procedures, which avoids bumping scheduled surgeries and overnight transplantation. This advancement on practice comes at a critical time when hospital resources are stretched and there are increased surgical backlogs due to the pandemic.

The study also suggests the new preservation temperature will allow more time to optimize immunologic matching between donor and recipients, and the possibility of performing lung transplantation in a semi-elective rather than urgent fashion.


Source: University Health Network 

21.04.2023

Read all latest stories

Related articles

Photo

Article • LTX overview

Lung transplant surgery: last hope for patients with advanced lung diseases

Despite treatment, chronic lung diseases such as COPD or cystic fibrosis can become so severe that a lung transplant is necessary. Dr Urte Sommerwerck explains which patients might be considered for…

Photo

News • Transplantation

Reduced the cytokine levels for more donor lungs

An animal study brings hope that more donor lungs could be used in the future. The researchers have launched a pilot study to investigate whether the treatment will have the same positive effects on…

Photo

News • Transplantation

Preserving donor lungs longer makes transplant more elective

A new method which doubles the usual time donor lungs can remain outside the body can benefit patients, staff and allow retrieval of donor lungs across greater geographical areas, says a study…

Related products

Alsachim – Dosimyco immunosupressant reagent kit (RUO)

Clinical Chemistry

Alsachim – Dosimyco immunosupressant reagent kit (RUO)

Alsachim, a Shimadzu Group Company
Arcovis 3000 S / R

Surgical II-C-Arms

Villa Sistemi Medicali · Arcovis 3000 S / R

VILLA SISTEMI MEDICALI s.p.a.
Cios Alpha

Surgical Flat Panel C-Arms

Siemens Healthineers · Cios Alpha

Siemens Healthcare GmbH
Cios Flow

Surgical Flat Panel C-Arms

Siemens Healthineers · Cios Flow

Siemens Healthcare GmbH
Cios Select

Surgical II-C-Arms

Siemens Healthineers · Cios Select

Siemens Healthcare GmbH
Cios Select with FD

Surgical Flat Panel C-Arms

Siemens Healthineers · Cios Select with FD

Siemens Healthcare GmbH
Subscribe to Newsletter